As a major pharmaceutical company that is constantly innovating and developing new treatments, Eli Lilly (NYSE: LLY) is always providing investors with additional reasons to consider buying its stock.

Eli Lilly ( LLY -1.72%) may seem like an expensive stock to invest in right now. It's trading at close to 90 times its trailing earnings. Its $720 billion market capitalization also means it's the most valuable healthcare stock in the world.

We recently compiled a list of the 16 Best Income Stocks To Buy According to Analysts. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other income stocks.

Shares of Eli Lilly & Co. LLY inched 0.87% higher to $789.12 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rema

Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market. It'll take a while for the economic implications of the data to play out. One of the most important questions about the competitive prospects of Lilly against Novo Nordisk in the market for anti-obesity medicines is,